IL130112A0 - Antigen-specific IgM detection - Google Patents

Antigen-specific IgM detection

Info

Publication number
IL130112A0
IL130112A0 IL13011297A IL13011297A IL130112A0 IL 130112 A0 IL130112 A0 IL 130112A0 IL 13011297 A IL13011297 A IL 13011297A IL 13011297 A IL13011297 A IL 13011297A IL 130112 A0 IL130112 A0 IL 130112A0
Authority
IL
Israel
Prior art keywords
antigen
specific igm
igm detection
detection
specific
Prior art date
Application number
IL13011297A
Other languages
English (en)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of IL130112A0 publication Critical patent/IL130112A0/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
IL13011297A 1996-11-29 1997-11-26 Antigen-specific IgM detection IL130112A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19649389A DE19649389A1 (de) 1996-11-29 1996-11-29 Antigenspezifischer IgM-Nachweis
PCT/EP1997/006583 WO1998023955A2 (de) 1996-11-29 1997-11-26 ANTIGENSPEZIFISCHER IgM-NACHWEIS

Publications (1)

Publication Number Publication Date
IL130112A0 true IL130112A0 (en) 2000-06-01

Family

ID=7813066

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13011297A IL130112A0 (en) 1996-11-29 1997-11-26 Antigen-specific IgM detection

Country Status (18)

Country Link
US (1) US6489129B1 (pt)
EP (1) EP0944832B1 (pt)
JP (1) JP3958797B2 (pt)
KR (1) KR20000057315A (pt)
CN (1) CN1245560A (pt)
AR (1) AR009638A1 (pt)
AT (1) ATE204082T1 (pt)
AU (1) AU720123B2 (pt)
BR (1) BR9714365A (pt)
CA (1) CA2272302A1 (pt)
DE (2) DE19649389A1 (pt)
ES (1) ES2162347T3 (pt)
IL (1) IL130112A0 (pt)
NO (1) NO992579L (pt)
NZ (1) NZ335754A (pt)
TW (1) TW434405B (pt)
WO (1) WO1998023955A2 (pt)
ZA (1) ZA9710726B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
CA2446246A1 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7387890B2 (en) 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ATE529436T1 (de) * 2007-04-20 2011-11-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CN102507932A (zh) * 2011-12-02 2012-06-20 无锡博慧斯生物医药科技有限公司 一种IgM抗体检测试纸条
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
SG11201608278WA (en) 2014-04-02 2016-10-28 Chembio Diagnostic Systems Inc Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3176580A1 (en) 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
CN105759059A (zh) * 2016-04-27 2016-07-13 丹娜（天津）生物科技有限公司 一种检测EV71病毒IgM抗体的免疫检测试剂盒及其制备方法
CN105974111B (zh) * 2016-07-20 2019-07-09 国家纳米科学中心 一种类风湿因子(IgM型)及其他抗原特异性IgM抗体联合检测的方法
CN107656057A (zh) * 2017-09-06 2018-02-02 中国农业科学院兰州兽医研究所 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用
EP3853612A4 (en) 2018-09-18 2021-10-27 Siemens Healthcare Diagnostics, Inc. PROCEDURES AND REAGENTS FOR CIKAVIRUS IMMUNOASSAYS
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒
CN119505004B (zh) * 2023-08-22 2026-02-24 重庆艾生斯生物工程有限公司 抗rf的抗体或其功能性片段及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
DE59511054D1 (de) 1994-07-25 2006-08-10 Roche Diagnostics Gmbh Bestimmung von spezifischem immunglobulin unter verwendung multipler antigene
ATE214073T1 (de) * 1994-07-25 2002-03-15 Roche Diagnostics Gmbh Hapten-markierte peptide
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz

Also Published As

Publication number Publication date
JP3958797B2 (ja) 2007-08-15
ES2162347T3 (es) 2001-12-16
DE19649389A1 (de) 1998-06-04
NO992579D0 (no) 1999-05-28
ZA9710726B (en) 1999-05-28
ATE204082T1 (de) 2001-08-15
EP0944832A2 (de) 1999-09-29
WO1998023955A2 (de) 1998-06-04
BR9714365A (pt) 2000-03-21
US6489129B1 (en) 2002-12-03
KR20000057315A (ko) 2000-09-15
AU720123B2 (en) 2000-05-25
WO1998023955A3 (de) 1998-07-23
AR009638A1 (es) 2000-04-26
EP0944832B1 (de) 2001-08-08
AU5751398A (en) 1998-06-22
CA2272302A1 (en) 1998-06-04
JP2001506749A (ja) 2001-05-22
CN1245560A (zh) 2000-02-23
TW434405B (en) 2001-05-16
NZ335754A (en) 2001-05-25
NO992579L (no) 1999-07-28
DE59704261D1 (de) 2001-09-13

Similar Documents

Publication Publication Date Title
IL130113A0 (en) Antigen-specific IgM detection
ZA9710726B (en) Antigen-specific IgM detection
GB9613015D0 (en) Device
ZA974878B (en) Device
GB9602507D0 (en) Device
IL122205A (en) Shutoff-opening device
GB9603256D0 (en) Antibodies
GB2328741B (en) Detection system
GB9603318D0 (en) Device
GB9619204D0 (en) Generator system
GB2319557B (en) Fixing device
GB9615679D0 (en) Detection means
GB2319602B (en) Light detection device
GB9603715D0 (en) Spray-suppression device
GB9615669D0 (en) Plant-watering device
GB9619577D0 (en) Retaining means
GB9617610D0 (en) Improved packaging system
GB9607209D0 (en) Detectors
GB9800600D0 (en) Detection system
GB9615058D0 (en) Detection system
GB9612909D0 (en) Detectors
GB9618409D0 (en) Detectors
GB9612260D0 (en) Detectors
DE69701493D1 (en) Photographisches system
GB9605214D0 (en) Detection